This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Peng, Z. Y. Articles by Wischmeyer, P. E. Search for Related Content PubMed PubMed Citation Articles by Peng, Z. Y. Articles by Wischmeyer, P. E. Social Bookmarking                         What's this?

Glutamine-Mediated Attenuation of Cellular Metabolic Dysfunction and Cell Death After Injury Is Dependent on Heat Shock Factor-1 Expression

From the Department of Anesthesiology, University of Colorado Health Sciences Center, Denver, Colorado

Correspondence: Paul Wischmeyer, MD, Director of Nutrition Support Service, Associate Professor of Anesthesiology, University of Colorado Health Sciences Center, Department of Anesthesiology, 4200 E. Ninth Avenue, Campus Box B113, Denver, CO 80262. Electronic mail may be sent to Paul.Wischmeyer{at}UCHSC.edu.

Background: Cellular metabolic dysfunction is associated with occurrence of multiple-organ failure after critical illness. Glutamine (GLN) attenuates cellular metabolic dysfunction in critical illness models. The mechanism of this protection is unclear. We previously demonstrated that GLN's benefit in critical illness might be due to enhanced heat shock protein (HSP) expression. We hypothesize that GLN's attenuation of cellular metabolic dysfunction is dependent on presence of heat shock factor-1 (HSF-1). Methods: HSF-1 wild-type and knockout mouse embryonic fibroblasts (HSF-1+/+ and HSF-1–/–) were used in all experiments. Cells were not treated, or were treated with 8 mmol/L GLN and immediately exposed to heat stress injury (45°C for 45 minutes). Cells were harvested for metabolic analysis by nuclear magnetic resonance (NMR) at 24 hours postinjury. Cell survival was assessed using the MTS assay. Results: GLN treatment in HSF-1+/+ cells led to significant attenuation of decreases in adenosine triphosphate (ATP)/adenosine diphosphate (ADP) ratio, phosphomonoester/phosphodiester (PME/PDE) ratio, and cell survival observed in non-GLN-treated HSF-1+/+ cells. In HSF-1–/– cells, the beneficial effect of GLN on preservation of ATP/ADP ratio, PME/PDE proliferation, and cell survival was lost. GLN-treated HSF-1–/– cells had a significant increase in extracellular lactate concentrations vs GLN-treated HSF+/+ cells. Conclusions: GLN treatment attenuated cellular metabolic dysfunction and improved cell membrane recovery only in HSF-1+/+ cells. Cellular injury, as measured by lactate release and cell survival assay, was improved by GLN treatment in HSF-1+/+ cells alone. Thus, GLN's beneficial effect on cellular metabolic dysfunction and cell survival appears to be dependent on HSF-1 expression.

Discussant

Author's Response

Journal of Parenteral and Enteral Nutrition, Vol. 30, No. 5, 373-379 (2006)
DOI: 10.1177/0148607106030005373


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				B. Taylor and J. Krenitsky Nutrition in the Intensive Care Unit: Year in Review 2008-2009 JPEN J Parenter Enteral Nutr, January 1, 2010; 34(1): 21 - 31. [Full Text] [PDF]